China Southern SSE STAR Growth ETF

Hygon Information Unveils World's First Post-Quantum Cryptography Smooth Migration Solution

Baili Tianheng's Innovative Drug SI-B036 Approved for Clinical Trials in Late-Stage Solid Tumors by NMPA

Belayidiantianheng Receives Approval for Clinical Trials of Iza-bren Combination Therapy

SmartSens released FY2026 Q1 earnings on April 30 After-Market (BJT), actual revenue CNY 2.112 B, actual EPS CNY 0.59

BLT released FY2026 Q1 earnings on April 29 Pre-Market (BJT), actual revenue CNY 325.91 M, actual EPS CNY 0.0611

Ninebot released FY2026 Q1 earnings on April 29 After-Market BJT, actual revenue CNY 5.87 B (forecast CNY 5.978 B), actual EPS CNY 0.266 (forecast CNY 0.2249)

Cambricon released FY2026 Q1 earnings on April 29 During-Market (BJT), actual revenue CNY 2.885 B (forecast CNY 1.793 B), actual EPS CNY 1.5973 (forecast CNY 0.7919)

BIOKIN PHARMACEUTICAL released FY2026 Q1 earnings on April 27 After-Market BJT, actual revenue CNY 94.59 M, actual EPS CNY -1.88

YUANJIE SEMICONDUCTOR released FY2026 Q1 earnings on April 27 After-Market (BJT), actual revenue CNY 355.28 M (forecast CNY 184.6 M), actual EPS CNY 1.4345 (forecast CNY 0.4827)

Piotech released FY2026 Q1 earnings on April 27 During-Market (BJT), actual revenue CNY 1.112 B (forecast CNY 1.061 B), actual EPS CNY 2

Huaguang Information Displays AI+Education Solutions and Builds Computing Cluster with Tongji University

SmartSens to Release FY2026 Q1 Earnings on April 30 After-Market (BJT)

Ninebot to Release FY2026 Q1 Earnings on April 30 After-Market (BJT), Forecast Revenue CNY 5.978 B, EPS CNY 0.2249

Cambricon to Release FY2026 Q1 Earnings on April 30 During-Market (BJT), Forecast Revenue CNY 1.793 B, EPS CNY 1.1

BLT to Release FY2026 Q1 Earnings on April 30, Pre-Market BJT

BLT to Release FY2025 Earnings on April 30 During-Market (BJT), Forecast Revenue CNY 1.851 B, EPS CNY 1.02

YUANJIE SEMICONDUCTOR to Release FY2026 Q1 Earnings on April 28 After-Market (BJT), Forecast Revenue CNY 184.6 M, EPS CNY 0.7

Biokin Pharmaceutical to Release FY2026 Q1 Earnings on April 28 After-Market BJT

Piotech to release FY2026 Q1 earnings report on April 28 during market hours (BJT), forecast revenue CNY 1.061 B

Biokin Pharmaceutical to release FY2025 earnings report on April 28 During-Market BJT, forecast revenue CNY 2.293 B, EPS CNY -1.1933

科创200

589700

588880

000688

588270

科创综指

000698

This week, the market faced pressure, with most leading hard technology stocks experiencing a pullback, but small-cap technology stocks performed relatively strongly. The STAR 200 ETF (588270) is worth paying attention to. Major STAR indices all saw declines, with the STAR 200 index down 0.6%, the STAR Growth index down 0.8%, the STAR 100 index down 1.9%, the STAR Composite index down 1.9%, and the STAR 50 index down 3.4%. Investment should be cautious, and funds carry risks

腾讯新闻 - 财经

Huatai-PB SSE Science and Technology Innovation Board 100 ETF

STAR 50

E Fund SSE Science and Technology Innovation Board 200 ETF

STAR 100

Small-cap technology stocks have been relatively active this week, focusing on the investment value of E Fund SSE Science and Technology Innovation Board 200 ETF (588270)

588080

588020

This week, the SSE STAR Growth Index rose by 1.0%, while the STAR 100 Index, STAR Composite Index, SSE STAR 50 Component Index, and STAR 200 Index fell by 1.2%, 3.5%, 4.0%, and 4.5%, respectively. Despite the overall poor market performance, the E Fund SSE STAR Growth ETF (588080) saw net capital inflows on three out of the first four trading days, indicating opportunities for capital allocation against the trend

E Fund China Science and Technology Innovation Board 50 Component ETF

E Fund SSE STAR Growth ETF

The performance of technology sectors is diverging, focus on the growth ETF E Fund (588020) and the Science and Technology Innovation Board 50 ETF E Fund (588080) for layout opportunities

This week, the STAR 200 Index fell by 1.3%, the STAR Composite Index fell by 1.9%, the STAR 100 Index fell by 2.1%, the SSE STAR Growth Index fell by 2.8%, and the SSE STAR 50 Component Index fell by 2.9%. According to data from the State Administration of Taxation, from January to February this year, the sales revenue of China's high-tech industry increased by 16.1% year-on-year, the sales revenue of the scientific research and technical service industry increased by 23.6% year-on-year, and the sales revenue of the core industries of the digital economy increased by 10.8% year-on-year. The low-altitude economy, commercial aerospace, and digital technology sectors performed remarkably, showcasing China's "hardcore" strength in technology

GF Fund SSE Science and Technology Innovation Board Growth ETF

Penghua STAR 100 ETF

Huatai-PB SSE Science and Technology Innovation Board 200 ETF

China's technology showcases "hardcore" strength, focusing on the medium to long-term allocation value of products like STAR 50 ETF E Fund (588080)

China Southern SSE STAR Growth ETF(589700.SH)

Small-cap technology stocks have been relatively active this week, focusing on the investment value of E Fund SSE Science and Technology Innovation Board 200 ETF (588270)

The performance of technology sectors is diverging, focus on the growth ETF E Fund (588020) and the Science and Technology Innovation Board 50 ETF E Fund (588080) for layout opportunities

China's technology showcases "hardcore" strength, focusing on the medium to long-term allocation value of products like STAR 50 ETF E Fund (588080)